Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: The PRECLOP study: Clinical impact and optimal cutoff value of on-treatment high platelet reactivity

Journal of the American College of Cardiology

Volumn 61, Issue 24, 2013, Pages 2428-2434

  Spiliopoulos, Stavros ^a   Pastromas, Georgios ^a   Katsanos, Konstantinos ^a   Kitrou, Panagiotis ^a   Karnabatidis, Dimitrios ^a   Siablis, Dimitrios ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

angioplasty; antiplatelet therapy; clopidogrel; femoropopliteal; high platelet reactivity; peripheral endovascular procedures; stenting

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PURINERGIC P2Y12 RECEPTOR;

ADULT; AGED; AMPUTATION; ANGIOPLASTY; ARTICLE; BYPASS SURGERY; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENDOVASCULAR SURGERY; EVENT FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PLATELET REACTIVITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REVASCULARIZATION; SENSITIVITY AND SPECIFICITY; STENT; TREATMENT OUTCOME;

AGED; BLOOD PLATELETS; DISEASE-FREE SURVIVAL; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; STENTS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84878952038     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.03.036     Document Type: Article

References (27)

1. L.K. Jennings Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis Thromb Haemost 102 2009 248 257
2. M. Gawaz, H. Langer, and A.E. May Platelets in inflammation and atherogenesis J Clin Invest 115 2005 3378 3384
3. D.L. Bhatt, K.A. Fox, and W. Hacke Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
4. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 7329 2002 71 86
5. F. Airoldi, A. Colombo, and N. Morici Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment Circulation 116 2007 745 754
6. G.W. Stone, S.G. Ellis, and A. Colombo Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation Circulation 115 2007 2842 2847
7. D.J. Angiolillo, A. Fernandez-Ortiz, and E. Bernardo Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives J Am Coll Cardiol 49 2007 1505 1516
8. V.L. Serebruany, S.R. Steinhubl, and P.B. Berger Variability in platelet responsiveness to clopidogrel among 544 individuals J Am Coll Cardiol 45 2005 246 251
9. S. Matetzky, B. Shenkman, and V. Guetta Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction Circulation 109 2004 3171 3175
10. P.A. Gurbel, K.P. Bliden, and K. Guyer Platelet reactivity in patients and recurrent events post-stenting results of the prepare post-stenting study J Am Coll Cardiol 46 2005 1820 1826
11. V.L. Serebruany, B.R. Oshrine, and A.I. Malinin Noncompliance in cardiovascular clinical trials Am Heart 150 2005 882 886
12. T.A. Nguyen, J.G. Diodati, and C. Pharand Resistance to clopidogrel: a review of the evidence J Am Coll Cardiol 45 2005 1157 1164
13. N.J. Breet, J.W. van Werkum, and H.J. Bouman Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
14. A. Malinin, A. Pokov, L. Swaim, M. Kotob, and V. Serebruany Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel Methods Find Exp Clin Pharmacol 28 2006 315 322
15. A. Malinin, A. Pokov, and M. Spergling Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study Thromb Res 119 2007 277 284
16. M.J. Price, S. Endemann, and R.R. Gollapudi Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J 29 2008 992 1000
17. R. Marcucci, A.M. Gori, and R. Paniccia Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up Circulation 119 2009 237 342
18. L. Bonello, U.S. Tantry, R. Marcucci Working Group on High On-Treatment Platelet Reactivity Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
19. A. Altenburg, and P. Haage Antiplatelet and anticoagulant drugs in interventional radiology Cardiovasc Intervent Radiol 35 2012 30 42
20. G. Tepe, R. Bantleon, and K. Brechtel Management of peripheral arterial interventions with mono or dual antiplatelet therapy - the MIRROR study: a randomised and double-blinded clinical trial Eur Radiol 22 2012 1998 2006
21. D. Alexopoulos, I. Xanthopoulou, and G. Tsigkas Predictors of high on-treatment platelet reactivity early after clopidogrel loading in ST-elevation myocardial infarction Circ J 76 2012 2183 2187
22. G. Patti, A. Nusca, F. Mangiacapra, L. Gatto, A. D'Ambrosio, and G. Di Sciascio Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention. Results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) Study J Am Coll Cardiol 52 2008 1128 1133
23. InterSociety Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur J Vasc Endovasc Surg 33 Suppl 1 2007 S63
24. S.S. Brar, J. ten Berg, and R. Marcucci Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data J Am Coll Cardiol 58 2011 1945 1954
25. G. Patti, V. Pasceri, V. Vizzi, E. Ricottini, and G. Di Sciascio Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study) Am J Cardiol 107 2011 995 1000
26. C. Gachet, and B. Aleil Testing antiplatelet therapy Eur Heart J Suppl 10 Suppl A 2008 A28 A34
27. J.W. Van Werkum, C.A. Van der Stelt, T.H. Seesing, C.M. Hackeng, and J.M. Ten Berg A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention J Thromb Haemost 4 2006 2516 2518